Literature DB >> 23994385

Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong.

Ada Wai-chi Lin1, Ka-hing Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23994385     DOI： 10.1016/j.jhep.2013.08.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

1.  A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.

Authors:  Brenna C Simons; Philip R Spradling; Dana J T Bruden; Carolyn Zanis; Samantha Case; Tammy L Choromanski; Minjun Apodaca; Hazel D Brogdon; Gaelen Dwyer; Mary Snowball; Susan Negus; Michael G Bruce; Chihiro Morishima; Cindy Knall; Brian J McMahon
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

2.  Surveillance and response of hepatitis B virus in Hong Kong Special Administrative Region, 1988-2014.

Authors:  Ada Wai-Chi Lin; Ka-Hing Wong
Journal:  Western Pac Surveill Response J       Date:  2016-02-03

3.  Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.

Authors:  Zhen-Zi Wang; Yu-Hua Gao; Wei Lu; Cun-Duo Jin; Ying Zeng; Ling Yan; Feng Ding; Tong Li; Xue-En Liu; Hui Zhuang
Journal:  Hum Vaccin Immunother       Date:  2016-11-22       Impact factor: 3.452

4.  Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.

Authors:  Naveen Gara; Adil Abdalla; Elenita Rivera; Xiongce Zhao; Jens M Werner; T Jake Liang; Jay H Hoofnagle; Barbara Rehermann; Marc G Ghany
Journal:  Clin Infect Dis       Date:  2014-11-10       Impact factor: 9.079

5.  Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community.

Authors:  Jing-Chen Ma; Zhi-Wei Wu; Hai-Song Zhou; Zhao Gao; Zhi-Yong Hao; Fei Jin; Yan-Hong Zhang; Min-Jie Li; Feng Wang; Qi Li; Sheng-Li Bi; Yu-Liang Zhao
Journal:  Hum Vaccin Immunother       Date:  2019-08-29       Impact factor: 3.452

6.  Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults.

Authors:  Juan Li; Fanyue Meng; Jingshan Zheng; Qi Liang; Huayu Li; Jingxin Li; Li Zhang; Jianhui Gan; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

Review 7.  Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?

Authors:  Hong Zhao; Yi-Hua Zhou
Journal:  Hum Vaccin Immunother       Date:  2017-12-06       Impact factor: 3.452

8.  Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic.

Authors:  Masataro Norizuki; Tomomi Kitamura; Kenichi Komada; Masaya Sugiyama; Masashi Mizokami; Anonh Xeuatvongsa; Vilasak Som-Oulay; Phengta Vongphrachanh; Munehito Machida; Koji Wada; Koji Ishii; Tomoko Kiyohara; Takaji Wakita; Masahiko Hachiya
Journal:  BMC Infect Dis       Date:  2019-06-10       Impact factor: 3.090

9.  Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016.

Authors:  Michael H Le; Yee Hui Yeo; Samuel So; Ed Gane; Ramsey C Cheung; Mindie H Nguyen
Journal:  JAMA Netw Open       Date:  2020-11-02

10.  Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.

Authors:  Ning Miao; Hui Zheng; Xiaojin Sun; Guomin Zhang; Fuzhen Wang
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.